EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41418-019-0435-1

PubMed Identifier: 31645677

Publication URI: http://europepmc.org/abstract/MED/31645677

Type: Journal Article/Review

Volume: 27

Parent Publication: Cell death and differentiation

Issue: 5

ISSN: 1350-9047